Miki Kosuke, Obara Naoshi, Makishima Kenichi, Sakamoto Tatsuhiro, Kusakabe Manabu, Kato Takayasu, Kurita Naoki, Nishikii Hidekazu, Yokoyama Yasuhisa, Sakata-Yanagimoto Mamiko, Hasegawa Yuichi, Chiba Shigeru
School of Medicine, University of Tsukuba, Tsukuba, Japan.
Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Case Rep Hematol. 2018 Oct 10;2018:7863943. doi: 10.1155/2018/7863943. eCollection 2018.
We report the case of a 76-year-old man who was diagnosed as having chronic myeloid leukemia (CML) with p190 while receiving treatment for symptomatic multiple myeloma (MM). The diagnosis of MM was based on the presence of serum M-protein, abnormal plasma cells in the bone marrow, and lytic bone lesions. The patient achieved a partial response to lenalidomide and dexamethasone treatment. However, 2 years after the diagnosis of MM, the patient developed leukocytosis with granulocytosis, anemia, and thrombocytopenia. Bone marrow examination revealed Philadelphia chromosomes and chimeric p190 mRNA. Fluorescence in situ hybridization also revealed -positive neutrophils in the peripheral blood, which suggested the emergence of CML with p190 . The codevelopment of MM and CML is very rare, and this is the first report describing p190 -type CML coexisting with MM. Moreover, we have reviewed the literature regarding the coexistence of these diseases.
我们报告了一例76岁男性患者的病例,该患者在接受有症状的多发性骨髓瘤(MM)治疗时被诊断为患有伴有p190的慢性髓性白血病(CML)。MM的诊断基于血清M蛋白的存在、骨髓中异常浆细胞以及溶骨性骨病变。患者对来那度胺和地塞米松治疗取得了部分缓解。然而,在MM诊断2年后,患者出现白细胞增多伴粒细胞增多、贫血和血小板减少。骨髓检查发现费城染色体和嵌合型p190 mRNA。荧光原位杂交还显示外周血中中性粒细胞呈阳性,提示出现了伴有p190的CML。MM和CML同时发生非常罕见,这是第一份描述p190型CML与MM共存的报告。此外,我们还回顾了关于这些疾病共存的文献。